Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes

Journal of Lipid Research

Volumn 57, Issue 2, 2016, Pages 310-317

  Zhang, Ying ^a   Jenkins, Alicia J ^b,c   Basu, Arpita ^d   Stoner, Julie A ^a   Lopes Virella, Maria F ^e,f   Klein, Richard L ^e,f   Lyons, Timothy J ^a,c  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d OKLAHOMA STATE UNIVERSITY   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Clinical trial; Dyslipidemia; High density lipoprotein; Intensive diabetes treatment; Low density lipoprotein; Nuclear magnetic resonance

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; BLOOD; CHEMISTRY; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADOLESCENT; ADULT; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84964240066     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P060657     Document Type: Article

References (52)

1. The Diabetes Control and Complications Trial Research Group . 1993 . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N. Engl. J. Med. 329 : 977 - 986 .
2. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group . 1999 . Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care . 22 : 99 - 111 .
3. Nathan , D. M. , P. A. Cleary , J. Y. Backlund , S. M. Genuth , J. M. Lachin , T. J. Orchard , P. Raskin , and B. Zinman ; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group . 2005 . Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353 : 2643 - 2653 .
4. Nathan , D. M. , J. Lachin , P. Cleary , T. Orchard , D. J. Brillon , J. Y. Backlund , D. H. O'Leary , and S. Genuth ; Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group . 2003 . Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N. Engl. J. Med. 348 : 2294 - 2303 .
5. Lachin , J. M. , T. J. Orchard , and D. M. Nathan ; DCCT/EDIC Research Group . 2014 . Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care . 37 : 39 - 43 .
6. Lachin , J. M. , S. Genuth , D. M. Nathan , B. Zinman , and B. N. Rutledge ; DCCT/EDIC Research Group . 2008 . Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial-revisited. Diabetes . 57 : 995 - 1001 .
7. Writing Team for the DCCT/EDIC Research Group . 2003 . Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA . 290 : 2159 - 2167 .
8. Stone , N. J. , J. G. Robinson , A. H. Lichtenstein , C. N. Bairey Merz , C. B. Blum , R. H. Eckel , A. C. Goldberg , D. Gordon , D. Levy , D. M. Lloyd-Jones , et al .; American College of Cardiology/American Heart Association Task Force on Practice Guidelines . 2014 . American College of Cardiology/American Heart Association Task Force on Practice, Guidelines: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation . 129 : S1 - S45 .
9. Sniderman , A. D. 2005 . Apolipoprotein B versus non-high-density lipoprotein cholesterol: and the winner is. Circulation . 112 : 3366 - 3367 .
10. deGoma , E. M. , J. W. Knowles , F. Angeli , M. J. Budoff , and D. J. Rader . 2012 . The evolution and refinement of traditional risk factors for cardiovascular disease. Cardiol. Rev. 20 : 118 - 129 .
11. BarterP.J. BallantyneC.M. CarmenaR. CabezasM.C. ChapmanM.J. CoutureP. GraafJ.D. DurringtonP.N. FaergemanO. FrohlichJ.et al.2006Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: Report of the thirty-person/ten-country panelJ. Intern. Med.259247-258
12. Sniderman , A. , K. Williams , and C. Cobbaert . 2009 . ApoB versus non-HDL-C: what to do when they disagree. Curr. Atheroscler. Rep. 11 : 358 - 363 .
13. Brunzell , J. D. , M. Davidson , C. D. Furberg , R. B. Goldberg , B. V. Howard , J. H. Stein , and J. L. Witztum . 2008 . Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J. Am. Coll. Cardiol. 51 : 1512 - 1524 .
14. Purnell , J. Q. , S. M. Marcovina , J. E. Hokanson , H. Kennedy , P. A. Cleary , M. W. Steffes , and J. D. Brunzell . 1995 . Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial. Diabetes . 44 : 1218 - 1226 .
15. Lyons , T. J. , A. J. Jenkins , D. Zheng , D. T. Lackland , D. McGee , W. T. Garvey , and R. L. Klein . 2004 . Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest. Ophthalmol. Vis. Sci. 45 : 910 - 918 .
16. Hoogeveen , R. C. , J. W. Gaubatz , W. Sun , R. C. Dodge , J. R. Crosby , J. Jiang , D. Couper , S. S. Virani , S. Kathiresan , E. Boerwinkle , et al . 2014 . Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler. Thromb. Vasc. Biol. 34 : 1069 - 1077 .
17. Mackey , R. H. , P. Greenland , D. C. Goff , Jr ., D. Lloyd-Jones , C. T. Sibley , and S. Mora . 2012 . High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). J. Am. Coll. Cardiol. 60 : 508 - 516 .
18. Mora , S. , J. D. Otvos , N. Rifai , R. S. Rosenson , J. E. Buring , and P. M. Ridker . 2009 . Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation . 119 : 931 - 939 .
19. Parish , S. , A. Offer , R. Clarke , J. C. Hopewell , M. R. Hill , J. D. Otvos , J. Armitage , and R. Collins ; Heart Protection Study Collaborative Group . 2012 . Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study. Circulation . 125 : 2469 - 2478 .
20. Steffen , B. T. , W. Guan , A. T. Remaley , P. Paramsothy , S. R. Heckbert , R. L. McClelland , P. Greenland , E. D. Michos , and M. Y. Tsai . 2015 . Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/ American College of Cardiology guidelines: the Multi-Ethnic Study of Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 35 : 448 - 454 .
21. Hsia , J. , J. D. Otvos , J. E. Rossouw , L. Wu , S. Wassertheil-Smoller , S. L. Hendrix , J. G. Robinson , B. Lund , and L. H. Kuller ; Women's Health Initiative Research Group . 2008 . Lipoprotein particle concentrations may explain the absence of coronary protection in the women's health initiative hormone trials. Arterioscler. Thromb. Vasc. Biol. 28 : 1666 - 1671 .
22. Otvos , J. D. , S. Mora , I. Shalaurova , P. Greenland , R. H. Mackey , and D. C. Goff , Jr . 2011 . Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J. Clin. Lipidol. 5 : 105 - 113 .
23. Jeyarajah , E. J. , W. C. Cromwell , and J. D. Otvos . 2006 . Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin. Lab. Med. 26 : 847 - 870 .
24. Rifai , N. , G. R. Warnick , and M. H. Dominiczak . 2000 . Handbook of Lipoprotein Testing. 2nd edition. AACC Press, Washington, DC .
25. Otvos , J. D. , E. J. Jeyarajah , D. W. Bennett , and R. M. Krauss . 1992 . Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin. Chem. 38 : 1632 - 1638 .
26. Tsai , M. Y. , A. Georgopoulos , J. D. Otvos , J. M. Ordovas , N. Q. Hanson , J. M. Peacock , and D. K. Arnett . 2004 . Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load. Clin. Chem. 50 : 1201 - 1204 .
27. Lyons , T. J. , A. J. Jenkins , D. Zheng , R. L. Klein , J. D. Otvos , Y. Yu , D. T. Lackland , D. McGee , M. B. McHenry , M. Lopes-Virella , et al .; DCCT/EDIC Research Group . 2006 . Nuclear magnetic resonancedetermined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness. Diabet. Med. 23 : 955 - 966 .
28. Jenkins , A. J. , T. J. Lyons , D. Zheng , J. D. Otvos , D. T. Lackland , D. McGee , W. T. Garvey , and R. L. Klein ; DCCT/EDIC Research Group . 2003 . Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int. 64 : 817 - 828 .
29. Jenkins , A. J. , T. J. Lyons , D. Zheng , J. D. Otvos , D. T. Lackland , D. McGee , W. T. Garvey , and R. L. Klein ; DCCT/EDIC Research Group . 2003 . Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care . 26 : 810 - 818 .
30. The DCCT Research Group . 1986 . The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes . 35 : 530 - 545 .
31. The DCCT Research Group . 1990 . Diabetes Control and Complications Trial (DCCT). Update. Diabetes Care . 13 : 427 - 433 .
32. Otvos , J. D. 2002 . Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin. Lab. 48 : 171 - 180 .
33. The DCCT Research Group . 1987 . Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. Clin. Chem. 33 : 2267 - 2271 .
34. . The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Arch. Ophthalmol. 113 : 36 - 51 .
35. Friedman , L. M. , C. D. Furberg , and D. L. Demets . 2010 . Fundamentals of Clinical Trials. Springer Science+Business Media, LLC, New York.
36. . The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes . 44 : 968 - 983 .
37. Nathan , D. M. , P. McGee , M. W. Steffes , and J. M. Lachin ; DCCT/ EDIC Research Group . 2014 . Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes . 63 : 282 - 290 .
38. Lachin , J. M. , N. H. White , D. P. Hainsworth , W. Sun , P. A. Cleary , and D. M. Nathan ; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group . 2015 . Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes . 64 : 631 - 642 .
39. Kingwell , B. A. , M. J. Chapman , A. Kontush , and N. E. Miller . 2014 . HDL-targeted therapies: progress, failures and future. Nat. Rev. Drug Discov. 13 : 445 - 464 .
40. Rosenson , R. S. , J. D. Otvos , and D. S. Freedman . 2002 . Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am. J. Cardiol. 90 : 89 - 94 .
41. Virani , S. S. , D. J. Catellier , L. A. Pompeii , V. Nambi , R. C. Hoogeveen , B. A. Wasserman , J. Coresh , T. H. Mosley , J. D. Otvos , A. R. Sharrett , et al . 2011 . Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis . 219 : 596 - 602 .
42. Mora , S. , M. Szklo , J. D. Otvos , P. Greenland , B. M. Psaty , D. C. Goff , Jr ., D. H. O'Leary , M. F. Saad , M. Y. Tsai , and A. R. Sharrett . 2007 . LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis . 192 : 211 - 217 .
43. Soedamah-Muthu , S. S. , Y. F. Chang , J. Otvos , R. W. Evans , and T. J. Orchard . 2003 . Pittsburgh Epidemiology of Diabetes Complications Study: Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia . 46 : 674 - 682 .
44. Albers , J. W. , W. H. Herman , R. Pop-Busui , E. L. Feldman , C. L. Martin , P. A. Cleary , B. H. Waberski , and J. M. Lachin . 2010 . Diabetes Control Complications Trial /Epidemiology of Diabetes Interventions Complications Research Group. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care . 33 : 1090 - 1096 .
45. Jermendy , G. 2012 . Vascular memory: can we broaden the concept of the metabolic memory? Cardiovasc. Diabetol. 11 : 44 .
46. Gold E.B. , BrombergerJ. , CrawfordS. , SamuelsS. , GreendaleG.A. , HarlowS.D. ,J. Skurnick2001 . Factors associated with age at natural menopause in a multiethnic sample of midlife women. AmJ. Epidemiol.153 : 865-874
47. Go , A. S. , D. Mozaffarian , V. L. Roger , E. J. Benjamin , J. D. Berry , W. B. Borden , D. M. Bravata , S. Dai , E. S. Ford , C. S. Fox , et al . 2013 . American Heart Association Statistics, Committee, Stroke Statistics, Subcommittee: Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation . 127 : e6 - e245 .
48. Zhang , Y. 2010 . Cardiovascular diseases in American women. Nutr. Metab. Cardiovasc. Dis. 20 : 386 - 393 .
49. Dabelea , D. , G. Kinney , J. K. Snell-Bergeon , J. E. Hokanson , R. H. Eckel , J. Ehrlich , S. Garg , R. F. Hamman , and M. Rewers ; Coronary Artery Calcification in Type 1 Diabetes Study Group . 2003 . Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes . 52 : 2833 - 2839 .
50. Colhoun , H. M. , M. B. Rubens , S. R. Underwood , and J. H. Fuller . 2000 . The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. J. Am. Coll. Cardiol. 36 : 2160 - 2167 .
51. Lloyd , C. E. , L. H. Kuller , D. Ellis , D. J. Becker , R. R. Wing , and T. J. Orchard . 1996 . Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler. Thromb. Vasc. Biol. 16 : 720 - 726 .
52. Laing , S. P. , A. J. Swerdlow , S. D. Slater , A. C. Burden , A. Morris , N. R. Waugh , W. Gatling , P. J. Bingley , and C. C. Patterson . 2003 . Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia . 46 : 760 - 765 .